Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China; The First School of Clinical Medicine, Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Oral Oncol. 2024 Nov;158:106980. doi: 10.1016/j.oraloncology.2024.106980. Epub 2024 Aug 15.
The early response to concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (LA-NPC) is closely correlated with prognosis. In this study, we aimed to predict early response using a combined model that combines sub-regional radiomics features from multi-sequence MRI with clinically relevant factors.
A total of 104 patients with LA-NPC were randomly divided into training and test cohorts at a ratio of 3:1. Radiomic features were extracted from subregions within the tumor area using the K-means clustering method, and feature selection was performed using LASSO regression. Four models were established: a radiomics model, a clinical model, an Intratumor Heterogeneity (ITH) score-based model and a combined model that integrates the ITH score with clinical factors. The predictive performance of these models was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA).
Among the models, the combined model incorporating the ITH score and clinical factors exhibited the highest predictive performance in the test cohort (AUC=0.838). Additionally, the models based on ITH score showed superior prognostic value in both the training cohort (AUC=0.888) and the test cohort (AUC=0.833).
The combined model that integrates the ITH score with clinical factors exhibited superior performance in predicting early response following concurrent chemoradiotherapy in patients with LA-NPC.
局部晚期鼻咽癌(LA-NPC)患者同步放化疗的早期反应与预后密切相关。本研究旨在通过结合多序列 MRI 的亚区放射组学特征与临床相关因素的综合模型来预测早期反应。
共 104 例 LA-NPC 患者被随机分为训练集和测试集,比例为 3:1。使用 K-means 聚类方法从肿瘤区域内的亚区提取放射组学特征,并使用 LASSO 回归进行特征选择。建立了四个模型:放射组学模型、临床模型、肿瘤内异质性(ITH)评分模型和整合 ITH 评分与临床因素的综合模型。使用受试者工作特征(ROC)曲线、校准曲线和决策曲线分析(DCA)评估这些模型的预测性能。
在测试集中,纳入 ITH 评分的综合模型表现出最高的预测性能(AUC=0.838)。此外,基于 ITH 评分的模型在训练集(AUC=0.888)和测试集(AUC=0.833)中均显示出优越的预后价值。
纳入 ITH 评分与临床因素的综合模型在预测 LA-NPC 患者同步放化疗后早期反应方面表现出优越的性能。